# TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES.

> **NIH NIH N01** · UNIVERSITY OF CALIFORNIA, SAN DIEGO · 2024 · $460,000

## Abstract

The contractor will identify novel adjuvant candidates that can be used to augment the efficacy of human vaccines. Research performed under this award will contribute to the pipeline of new adjuvant leads that either: (a) exploit the natural capacity of the innate immune system to initiate and sustain effective T and B cell responses and to induce long term immune memory, or (b) act directly on cells of the adaptive immune system to enhance their response to pathogen-derived antigens.

## Key facts

- **NIH application ID:** 11074014
- **Project number:** 75N93019C00042-P00020-9999-2
- **Recipient organization:** UNIVERSITY OF CALIFORNIA, SAN DIEGO
- **Principal Investigator:** DENNIS CARSON
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $460,000
- **Award type:** —
- **Project period:** 2019-09-30 → 2026-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11074014

## Citation

> US National Institutes of Health, RePORTER application 11074014, TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES. (75N93019C00042-P00020-9999-2). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/11074014. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*